tradingkey.logo

Collplant Biotechnologies Reports 2025 Third Quarter Financial Results

ReutersNov 26, 2025 12:41 PM

- Collplant Biotechnologies Ltd CPTG.F:

  • COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

  • COLLPLANT BIOTECHNOLOGIES 9M OPERATING EXPENSES USD 10 MILLION

  • COLLPLANT BIOTECHNOLOGIES 9M ADJUSTED NET INCOME USD -7 MILLION

  • COLLPLANT BIOTECHNOLOGIES 9M ADJUSTED EPS USD -0.58

  • COLLPLANT BIOTECHNOLOGIES 9M REVENUE USD 2.3 MILLION

  • COLLPLANT BIOTECHNOLOGIES 9M NET INCOME USD -8.3 MILLION

  • COLLPLANT BIOTECHNOLOGIES 9M EPS USD -0.69

  • COLLPLANT BIOTECHNOLOGIES LTD - RECENTLY UPDATED ITS EXPENSE FORECAST AND HAS INITIATED A COST CUTTING AND WORKFORCE REDUCTION PLAN

  • COLLPLANT BIOTECHNOLOGIES: UPDATED ALLOCATION OF RESOURCES TO RESULT IN REDUCTION IN WORKFORCE BY ABOUT 25%

  • COLLPLANT BIOTECHNOLOGIES LTD - ROGER POMERANTZ STEPS DOWN AS CHAIRMAN; YEHIEL TAL NOMINATED AS INTERIM CHAIRMAN

  • COLLPLANT BIOTECHNOLOGIES LTD - ROGER POMERANTZ STEPS DOWN AS CHAIRMAN; YEHIEL TAL NOMINATED AS INTERIM CHAIRMAN

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI